CompletedNCT00854737
Cytidine and omega-3 supplements for bipolarity
About this title
Cytidine and Omega-3 Fatty Acids in Bipolar Disorder
Read the official source — NCT00854737Placebo comparisonAges 18–55United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
- Listed locations
- Belmont and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJuly 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 90
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Dietary supplement, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00854737
- Official title
Show the full official title
A Combination of Cytidine and Omega-3 Fatty Acids in Bipolar Disorder: Are There Additive or Synergistic Mood Stabilizing Effects?
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Belmont · Neptune City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including placebo.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
